Nov. 14, 2017—Food and Drug Administration approved the first medication that tracks whether you took it.
Oct. 17, 2017—Consumers will be hurt by the Trump administration’s moves to change the Affordable Care Act (ACA), experts tell us. The only questions are by how much and whether that will change in the years ahead.
Aug. 30, 2017—Food and Drug Administration approved the first immunotherapy treatment in the United States.
June 13, 2017—Food and Drug Administration approved a generic version of a medication that has proved to be effective—and extraordinarily costly—in the prevention of HIV-1.
May 24, 2017—Food and Drug Administration approved the first medication that’s designed to treat cancer patients whose cancer has a specific genetic feature, or biomarker, rather than being based on the location where a tumor was found.
May 8, 2017—Food and Drug Administration approved the first new medication for the treatment for amyotrophic lateral sclerosis (ALS), which is commonly known as Lou Gehrig’s disease, in 22 years.
March 30, 2017—McDonald’s is changing the Quarter Pounder.
March 30, 2017—As expected, Food and Drug Administration approved ocrelizumab for the treatment of adults who have one of several forms of multiple sclerosis (MS).
Feb. 9, 2017—Food and Drug Administration granted its first approval of a corticosteroid to treat Duchenne muscular dystrophy (DMD).
Nov. 10, 2016—Change will come to how some consumers buy health insurance—the recent presidential election all but guarantees it—but two experts tell Consumers Digest that any changes likely won’t take effect in 2017. In other words, consumers who are eligible to buy insurance through the Affordable Care Act (ACA) marketplace should act as though nothing has changed.
Nov. 1, 2016—The makers of MyPillow bedding might be resting a little less easy after reaching a settlement with California over claims that the company violated false-advertising laws.
Sept. 22, 2016—Food and Drug Administration approved the first medication for patients who have Duchenne muscular dystrophy (DMD).
Sept. 2, 2016—Food and Drug Administration approved a final rule that banned 19 active ingredients that are used in antibacterial soaps, because the soapmakers couldn’t back claims that the ingredients were safe and more effective than plain soap and water.
Aug. 31, 2016—If you like to swim as part of your fitness routine and you own a Fitbit fitness tracker, you’ve had to ditch the device before diving into the pool. That’s about to change.
Aug. 9, 2016—The federal government is joining the fight against scammers looking to cash in on Zika fears.
Aug. 4, 2016—The outbreak of diseases can be worrisome. Unfortunately, scammers always are at the ready to provide bogus solutions that do nothing but defraud consumers. Their latest target: Zika fears.
July 6, 2016—Food and Drug Administration approved the use of the first fully absorbable stent to treat coronary artery disease.
June 30, 2016—Food and Drug Administration approved a medication to treat adults who have chronic hepatitis C. The medication also is approved in combination with ribavirin to treat patients who have moderate-to-severe cirrhosis (advanced liver disease).
June 13, 2016—Food and Drug Administration approved the first vaccine that’s meant to prevent consumers who travel to cholera-affected areas from getting the disease.
June 2, 2016—Food and Drug Administration approved a treatment for adults who have relapsing forms of multiple sclerosis (MS).